0001123292-17-001439.txt : 20170921 0001123292-17-001439.hdr.sgml : 20170921 20170921155405 ACCESSION NUMBER: 0001123292-17-001439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170710 FILED AS OF DATE: 20170921 DATE AS OF CHANGE: 20170921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Palczuk Linda CENTRAL INDEX KEY: 0001717580 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 171095814 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-07-10 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001717580 Palczuk Linda 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 1 0 0 President & CEO Incentive Stock Option (right to buy) 6.67 2017-07-10 4 A 0 25000 6.67 A 2018-07-10 2027-07-10 Common Stock 25000 25000 D 6,250 shares underlying this option shall vest on each of July 10, 2018, July 10, 2019, July 10, 2020, and July 10, 2021, subject to Reporting Person's continued service through the applicable vesting date. /s/ Linda Palczuk 2017-09-21